A−90/100
Desk Score
Dispatch #2Partner
Invigor Medical
A long-running pharmacy operator with steady mid-market pricing and a broad wellness catalog.
Visit Invigor Medical ↗Partner — we may earn a commission, at no cost to you. It never changes the Desk Score.
- Semaglutide
- $199/mo
- Tirzepatide
- $339/mo
- Coverage
- Not disclosed
- Brand-name
- Compounded only
Desk Score breakdown
Each of the six scored dimensions. See the methodology.
Price transparency85/100
State access78/100
Molecule range88/100
Onboarding speed90/100
Support responsiveness88/100
Licensing & trust92/100
What the Desk likes
- Mid-market pricing on both molecules
- Established multi-year operator
- Broad catalog beyond GLP-1
Where points come off
- States-served list not publicly disclosed
- Compounded only
The Desk's briefing — A−
Best for: Patients who want GLP-1 care within a wider, established health program.
Pricing and verification reflect Invigor Medical's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Invigor Medical's site. Not medical advice; see our disclosure.